NIPT is one of the most accurate prenatal methods for determining fetal sex, but it is not infallible. A large meta-analysis of 90 studies found an average sensitivity of about 97% and specificity of about 99%, which means a small but real number of results turn out to be wrong. The reasons range from simple timing issues to rare biological quirks that most expectant parents have never heard of, and understanding those edge cases matters far more than the headline accuracy numbers suggest.
How Accurate the Numbers Really Are
A comprehensive health technology assessment pooling data from multiple studies reported that NIPT’s sensitivity for fetal sex is 98.9% and its specificity is 99.6%, with correspondingly high predictive values of 99.6% (positive) and 98.8% (negative).1Health Technology Assessment. Non-invasive prenatal testing (NIPT) for foetal sex determination A separate meta-analysis covering 90 studies and more than 10,500 tests found slightly lower but still impressive figures: about 97% sensitivity and 99% specificity.2PubMed Central. Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis In practical terms, if NIPT says you’re carrying a boy, there is roughly a 99 in 100 chance it’s correct. If it says girl, the odds are similarly strong.
Those numbers sound reassuring, and for most pregnancies they are. But “highly accurate” and “never wrong” are very different things. Across the millions of NIPT tests performed worldwide each year, even a fraction-of-a-percent error rate means thousands of families receive an incorrect sex result. So the more useful question is not whether NIPT can be wrong, but why and when it is most likely to be wrong.
Why the Timing of Your Blood Draw Matters
NIPT works by analyzing fragments of placental DNA circulating in your blood. Early in pregnancy, there just isn’t much of that DNA floating around yet, and the proportion of fetal DNA relative to your own DNA (known as the fetal fraction) is low. The test’s accuracy climbs as the fetal fraction rises with gestational age. Before week 7, sensitivity for fetal sex drops to about 75%, meaning roughly one in four results could be a miss. Between weeks 7 and 12, sensitivity jumps to about 95%. After week 20, it exceeds 99%.1Health Technology Assessment. Non-invasive prenatal testing (NIPT) for foetal sex determination
Most providers draw blood for NIPT at 10 weeks or later, which puts patients well within the high-accuracy window. But some commercial tests marketed directly to consumers can be ordered earlier, and the earlier the draw, the greater the chance the result is wrong. Blood samples taken before gestational week 7 provide less reliable results than those taken afterward.3PubMed. Non‐Invasive Prenatal Testing (NIPT) for Fetal Sex Determination If you’re considering an early at-home kit, the timing of the sample is probably the single most important factor determining whether you can trust the sex call.
How Body Weight Affects Fetal Fraction
The fetal fraction doesn’t only depend on how far along you are. Maternal weight has a meaningful effect. In one study, women with a normal BMI had an average fetal fraction of about 12.5%, while women classified as obese averaged about 9.2%. The rate of inconclusive or “indeterminate” results was about five times higher in the obese group (roughly 8% versus under 2%), and women with obesity were more than six times as likely to receive an inconclusive first-trimester NIPT result after adjusting for other variables.4PubMed Central. Low fetal fraction in obese women at first trimester cell-free DNA based prenatal screening is not accompanied by differences in total cell-free DNA
A larger dataset of nearly 26,000 pregnancies confirmed the pattern. Low fetal fraction occurred in about 4.5% of normal-weight women compared with roughly 20% of obese women, rising to over 35% in women with severe obesity. Higher BMI was a strong negative predictor of fetal fraction, while advancing gestational age was a positive predictor, though the effect of BMI was far more powerful.5PubMed Central. Impact of Maternal Body Mass Index (BMI) on the Performance of Non‐Invasive Prenatal Testing (NIPT) The practical takeaway: if you have a higher BMI, you have a higher chance of an inconclusive result, and waiting a week or two longer before drawing blood can help push the fetal fraction above the lab’s minimum threshold.
Vanishing Twins Can Linger in Your Blood
One of the more surprising sources of error involves pregnancies that started as twins. In early pregnancy, it’s not uncommon for one embryo to stop developing while the other continues normally. This is sometimes called a “vanishing twin.” The catch is that the placental tissue from the vanished twin can keep releasing DNA fragments into the mother’s bloodstream for weeks afterward. If that twin had a different chromosomal sex from the surviving fetus, the leftover DNA can confuse the test.
Research has shown that DNA from a vanished twin can influence NIPT results for at least 7 to 8 weeks after the twin stops developing, and in some cases up to 12 to 14 weeks.6PubMed. False positive non-invasive prenatal testing results due to vanishing twins If an early ultrasound showed two gestational sacs but a later scan showed only one, that history is worth flagging for whoever interprets your NIPT results. Without that context, the lab has no way to know that the Y-chromosome signal it picked up came from a twin that’s no longer developing.
When the Mother’s Own Chromosomes Create Confusion
NIPT reads a mixture of maternal and fetal DNA, and the test algorithms assume the mother’s chromosomal makeup is straightforward. For most people it is. But some women carry a subtle mix of cell lines with different sex chromosomes, a condition called sex chromosome mosaicism, without ever knowing about it. A woman might have a majority of cells with the typical XX pattern and a smaller population of cells missing one X. She may have gone her entire life without symptoms or any reason to suspect anything unusual.
That hidden mosaicism can throw off the NIPT reading. In one study of women who received a false-positive NIPT flag for X-chromosome loss, over a third turned out to have mosaic or altered maternal sex chromosome patterns when their own blood cells were tested.7PubMed. Contribution of maternal mosaicism to false-positive chromosome X loss associated with noninvasive prenatal testing A larger study of nearly 195,000 NIPT cases found that about 1 in 1,300 returned uninformative results because of a suspected maternal X-chromosome abnormality. When maternal samples were checked, the vast majority, about 94%, confirmed an actual maternal chromosome variant. The most common finding was mosaicism for Turner syndrome (a mix of 45,X and 46,XX cells).8American Journal of Obstetrics & Gynecology MFM. Detection of maternal X chromosome abnormalities using single nucleotide polymorphism–based noninvasive prenatal testing
This means that, in rare cases, NIPT doesn’t just reveal information about the fetus. It inadvertently surfaces a genetic finding about the mother herself. An earlier study from Taiwan also demonstrated that maternal sex chromosome mosaicism can directly cause discordant sex chromosome results on NIPT.9Taiwanese Journal of Obstetrics and Gynecology. Maternal mosaicism of sex chromosome causes discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing If your NIPT flags something unexpected about the sex chromosomes, it doesn’t necessarily mean the fetus has a condition. It could be picking up your own cells.
Organ Transplants and Other Rare Signals
An even rarer but well-documented cause of sex discordance involves women who received an organ or stem cell transplant from a male donor before becoming pregnant. Transplanted cells can persist in the recipient’s body for years, and if those donor cells are shedding DNA into the bloodstream, NIPT may detect Y-chromosome fragments that have nothing to do with the fetus.
In one case report, a pregnant woman who had previously received a male-donor bone marrow transplant had her cell-free DNA broken down into its sources: roughly 21% came from the fetus, about 66% from the transplanted hematopoietic cells, and about 14% from her own non-hematopoietic tissue.10PubMed Central. Noninvasive prenatal screening in a pregnant woman with a history of stem cell transplant from a male donor: A case report and literature review Another case found that 100% of a woman’s analyzed lymphocyte nuclei showed a Y chromosome from a prior male bone marrow transplant.11PubMed Central. Chromosome Y as a marker for sex discrepancies in patients with organ transplants: a case report In such cases, a standard NIPT would almost certainly call the fetus male regardless of actual fetal sex. Any transplant history, especially from a male donor, needs to be part of the clinical conversation before NIPT is ordered.
Sex Chromosome Conditions and Much Lower Accuracy
There’s an important distinction between NIPT telling you “boy or girl” and NIPT flagging a sex chromosome condition such as Turner syndrome (45,X), Klinefelter syndrome (47,XXY), or Triple X syndrome (47,XXX). The headline accuracy numbers of 97% to 99% apply to straightforward sex determination. When the test flags an actual sex chromosome abnormality, its positive predictive value drops considerably.
One study of over 10,000 pregnancies found that the overall positive predictive value for sex chromosome conditions was only about 55%. For Turner syndrome specifically, only about 29% of positive NIPT calls were confirmed by karyotyping. Klinefelter syndrome fared better at about 78%, and Triple X syndrome was confirmed in all five flagged cases.12PubMed Central. Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood Other studies have produced broadly similar findings: Turner syndrome consistently has the lowest confirmation rate, often under 30%, while Klinefelter and XYY syndrome typically confirm at higher rates.13PubMed. Non-invasive prenatal testing in detecting sex chromosome aneuploidy: A large-scale study in Xuzhou area of China14PubMed. Clinical experience regarding the accuracy of NIPT in the detection of sex chromosome abnormality
The reason Turner syndrome generates so many false positives ties back to the maternal mosaicism issue discussed above. If the mother is unknowingly losing X chromosomes in some fraction of her cells, the test can mistake that signal for a fetal condition. For anyone who receives an NIPT flag for a sex chromosome abnormality, the result should be treated as a screening flag, not a diagnosis. Confirmatory testing is essential before making any clinical decisions.
When Chromosomal Sex and Physical Sex Don’t Match
NIPT reads chromosomes, not anatomy. In the vast majority of pregnancies, chromosomal sex (XX or XY) aligns with the physical development you’d see on ultrasound. But in some cases it doesn’t, and this creates a category of “error” that isn’t really a test error at all. Conditions collectively called differences of sex development (DSDs) involve a mismatch between chromosomal sex and physical traits. For instance, a fetus with XY chromosomes and androgen insensitivity syndrome may develop external anatomy typically associated with female sex.15Pediatric Surgical Procedures – An Updated Guide – Volume 2. Disorders of Sex Development and Androgen Insensitivity Syndrome
In such a case, NIPT would correctly report XY chromosomes, and a later ultrasound might show anatomy that looks female. Both results are “correct” in their own domain, but the discordance can be deeply confusing for parents. Increased use of NIPT has led to more prenatal detection of these discrepancies, as the chromosomal information becomes available earlier than it would from ultrasound alone.16PubMed Central. Prenatal detection and evaluation of differences of sex development This is a situation where the test isn’t wrong in a technical sense, but the result doesn’t tell the whole story.
What Happens When NIPT and Ultrasound Disagree
If your NIPT result says one sex and your anatomy scan says another, the clinical pathway is well established but requires careful navigation. The first step is ruling out human error: mislabeled tubes, mixed-up samples, or clerical mistakes. When a method based on genetic fingerprinting (called SNP-based NIPT) is used, the lab can verify that the original sample actually belongs to you by re-checking the maternal DNA pattern.17PubMed Central. Fetal Sex Results of Noninvasive Prenatal Testing and Differences With Ultrasonography
If the discrepancy holds after ruling out mix-ups, and if ultrasound was performed by an experienced examiner after 16 weeks with good visualization, the recommended next step is amniocentesis rather than chorionic villus sampling. The reason for preferring amniocentesis is that the placenta can harbor its own chromosomal quirks (confined placental mosaicism) that wouldn’t reflect the fetus’s actual chromosomes. If a discrepancy still persists after amniocentesis, expert guidelines recommend bringing in a multidisciplinary team to review all available information and map out a care plan for the family.17PubMed Central. Fetal Sex Results of Noninvasive Prenatal Testing and Differences With Ultrasonography
Inconclusive Results and the Redraw Option
Not every NIPT result is a clear “boy” or “girl.” Sometimes the lab reports an inconclusive or uninformative result, typically because the fetal fraction was too low for the algorithm to make a confident call. This is not the same as a wrong result; it’s the test saying it doesn’t have enough information. One study examined 189 women who received uninformative first-round results due to low fetal fraction. After a second blood draw, about 59% got a clear result. The remaining 41% were still inconclusive.18PubMed Central. Insights into non-informative results from non-invasive prenatal screening through gestational age, maternal BMI, and age analyses
In rare cases, an inconclusive sex result may itself be a signal. A case report described a pregnancy where NIPT could not determine fetal sex, and subsequent amniocentesis revealed confined placental mosaicism as the likely cause.19The Journal of Reproduction. Inconclusive prenatal sex determination in an NIPT due to probable confined placental mosaicism and the importance of amniocentesis So while an inconclusive result is frustrating, it’s worth discussing with your provider rather than simply assuming the test failed. The reason the test couldn’t return a clear answer sometimes matters.
The Counseling Gap
A recurring theme in the clinical literature is that many patients go into NIPT without fully understanding what the test can and cannot do. A survey of genetic counselors found that one of the biggest challenges was inadequate pretest counseling by other healthcare providers. Patients often came in expecting NIPT to be diagnostic, when it is actually a screening test. The distinction matters: a screening test flags elevated risk, while a diagnostic test confirms a condition. This gap in understanding is amplified when NIPT is marketed commercially with emphasis on its high accuracy for fetal sex, which can lead parents to treat the sex call as absolute.20PubMed. Genetic counseling for fetal sex prediction by NIPT: Challenges and opportunities
For straightforward male-versus-female determination, the distinction between “screening” and “diagnostic” is less of a problem in practice, because the accuracy is genuinely high. But if the result flags a sex chromosome abnormality, the distinction becomes critical. A positive screen for Turner syndrome, with its confirmation rate sometimes below 30%, is a very different thing from a confirmed Turner syndrome diagnosis. Acting on the screening result alone, without confirmatory amniocentesis, would be premature.
Twin Pregnancies
If you’re expecting twins, the accuracy picture depends on whether the twins are identical or fraternal. Identical twins share chromosomes, so determining sex is no different from a singleton pregnancy. Fraternal twins can have different sexes, which makes the lab’s job harder because it needs to sort out which DNA belongs to which twin. A validation study of SNP-based NIPT in twin pregnancies reported 100% accuracy for individual fetal sex across 102 twin cases, though the confidence interval suggests the true accuracy could be somewhat lower.21PubMed Central. Validation of a Single-Nucleotide Polymorphism-Based Non-Invasive Prenatal Test in Twin Gestations: Determination of Zygosity, Individual Fetal Sex, and Fetal Aneuploidy The data on twins remains thinner than for singletons, so the headline accuracy rates from large meta-analyses don’t automatically transfer.
Legal Restrictions on Fetal Sex Disclosure
In much of North America, Europe, and Australia, finding out your baby’s sex via NIPT is a straightforward consumer choice. But the global picture is more complicated. In India and China, legislation prohibits fetal sex determination entirely because of concerns about sex-selective termination. Enforcement has proven difficult, and violations are widespread, sometimes through illegal clinics and sometimes by mailing blood samples to countries where the testing is legal. In Germany, fetal sex may only be disclosed after week 12 of gestation.22Oxford Academic. Regulating non-invasive prenatal testing (NIPT) for fetal sex determination
The ease of NIPT has sharpened these policy tensions. Unlike ultrasound, which requires a trained operator and a machine, NIPT only requires drawing blood and mailing it to a lab, potentially in another country. This portability makes it harder for countries with sex-determination bans to enforce their laws, and it raises questions about how international regulation can keep pace with the technology. For families in jurisdictions where sex determination is restricted, the legal landscape adds another layer to an already complex decision.
Medical Reasons for Wanting an Early Sex Result
For many parents, finding out fetal sex through NIPT is simply about curiosity or preparation. But for some families, early sex determination is medically relevant. Certain genetic conditions are X-linked, meaning they primarily affect male fetuses. Families known to carry these conditions have historically relied on invasive procedures like amniocentesis or chorionic villus sampling to determine sex, both of which carry a small risk of miscarriage. NIPT offers a way to identify which pregnancies need that invasive follow-up: only those carrying a male fetus would proceed to diagnostic testing, sparing female-carrying pregnancies from unnecessary procedures.1Health Technology Assessment. Non-invasive prenatal testing (NIPT) for foetal sex determination In this context, the stakes of a wrong sex call are higher than nursery paint colors. A false female result could delay diagnosis of a serious condition, while a false male result could lead to an unnecessary invasive procedure. The test’s high accuracy makes both scenarios rare, but they underline why understanding the limits of NIPT remains clinically important, not just a matter of curiosity.